NAM Use for Regulatory Application

Implementing agentic AI workflows for safer products with Human Chemical

Friday, January 16, 2026
1 pm ET / 18:00 UTC

This training with Mattson Thieme, PhD, and Isaac Wilks, co-founders of the Human Chemical Company co-founders, an AI lab focused on safer chemistry, will equip toxicologists to leverage cutting-edge agentic AI as a force multiplier for their expertise. Get more details at www.pcrm.org/NAMSpotlight.

Register

The FDA ISTAND Program: A Guide to Replacing Animal Experiments with Your Method 

Wednesday, January 28, 2026
1 pm ET / 18:00 UTC

Dr. Michael Phelan, founder of InnovApproach Consulting, will describe his experiences as the lead of the first ever submission accepted into the ISTAND program, including a step-by-step guide to preparing for and completing each phase of the ISTAND program. Get more details at www.pcrm.org/FDA.

Register

NURA en Español: Desarrollo de métodos in vitro para el estudio de fototoxicidad 

Miércoles, 4 de febrero de 2026
[Wednesday, February 4, 2026]
10 am ET / 16:00 CET

En este seminario web en español, la Prof. Dra. Pilar Vinardell describirá los métodos in vitro existentes en irritación y sensibilización dérmica, así como las estrategias para desarrollar nuevos enfoques de fototoxicidad que no requieren el uso de animales de laboratorio. Obtenga más información en www.pcrm.org/NURAenEspanol.

In this Spanish-language webinar, Prof. Dra. Pilar Vinardell will describe the existing in vitro methods in dermal irritation and sensitization and the strategies for developing new phototoxicity approaches that do not require the use of laboratory animals. Get more details at www.pcrm.org/NURAenEspanol.

REGÍSTRESE

NURA is developing several new in-person and virtual training opportunities, including:

• NAMs for Sunscreens
• Xeno-free reagents in toxicology safety assessments
• A Hands-on QSAR Training
• Validation of NAMs

Join our mailing list to get updates on our latest learning opportunities. You can also use the form to provide feedback and suggest training topics. Alternatively, you can email us with your comments and suggestions at nura [at] pcrm.org. 

We would like to feature your human-based nonanimal approach in a webinar. 

You will have the opportunity to present your method to a diverse professional audience from industry, government, NGOs, and academia, followed by an audience-led Q&A session. We are looking for:

• Case studies of NAMs that have been submitted in FDA applications.
• NAMs currently being used in regulatory applications or those that have the potential to replace animal use in regulatory applications.

Please submit your presentation title and abstract or speaker suggestion to nura [at] pcrm.org. 

Connect With Us